Announced Mon, 13 Jul · 18:37 IST
Routine compliance certificate under SEBI Regulation 74(5) for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹49.99
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.4-0.2-0.1-1.2-0.6+1.2————
Up moveDown movePending
AI summary
Eiko Lifesciences submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate, issued by their Registrar Bigshare Services Pvt. Ltd., confirms that no dematerialisation requests for equity shares were received between 1 April and 30 June 2026. Filed by Company Secretary Chintan Doshi.
Likely market impact
Routine compliance filing with no material impact on the stock or shareholders.